Triage Tox Drug Screen, Model 94400
510(k) K060791
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK060791 | Date22 Jun 2006 | StatusActive |
Recalls
-
- Terminated Z-1214-2014
Alere San Diego, Inc. is initiating a recall of the Alere Triage TOX Drug Screen, Catalog Number 94400, Lots W56013B and W56035B because Alere's investigation has shown that these lots have a frequency of false negative results for PCP (Phencyclidine) that is higher than the frequency shown in the package insert. If you have questions about previously reported results.
-
- Terminated Z-2460-2012
Alere San Diego is recalling Alere Triage TOX Drug Screen because there is a possibility that after installing the code chip provided with the affected lots: AMP, BAR, and PCP, the threshold ranges may not be consistently set correctly in all meters.
-
- Terminated Z-2039-2012
A recall was initiated because Alere San Diego has confirmed that the Triage TOX Drug Screen may have significantly decreased precision and accuracy than claimed. An increased frequency of false positive and/or false negative results has been observed for Triage TOX Drug Screen.
-
- Terminated Z-1446-2012
The recall was initiated because Biosite Inc. received an increase in customer calls regarding unexpected positive THC results when using the Triage TOX Drug Screen.
-
- Terminated Z-0029-2013
Biosite is recalling the Triage TOX Drug Screen kits where the box containing test devices because it was mislabeled.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DJR
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.3620
- Advisory Committee
- Clinical Toxicology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 6 Oct 2026
The Triage Tox Drug Screen, Model 94400 is an enzyme immunoassay test system for methadone, classified under product code DJR and regulation number 862.3620. It is designed for use in clinical toxicology settings to detect methadone in specimens.
The device was cleared by the FDA through the 510(k) process (K060791) on June 22, 2006, and is classified as a Class II device with special controls. It is manufactured by Biosite Incorporated in San Diego, California.